What are some of the other HIV vaccine initiatives that are underway?
At present, a whole new generation of candidate HIV vaccines are under development, in particular those based on globally prevalent HIV strains, which may be more appropriate for use in developing countries. These candidate vaccines are developed under frameworks of different national agencies in private and public sectors, including among others the US National Institute of Health (NIH), European research Institutions, the International AIDS Vaccine Initiative (IAVI) and the European Union (EU), as well as an increasing number of national HIV vaccine programmes and research institutions in developing countries. WHO, UNAIDS and the African AIDS Vaccine Programme (AAVP) are committed to supporting the developing countries in building capacity to conduct clinical trials at the highest scientific and ethical standards. The recently announced Global HIV Vaccine Enterprise sponsored by the Gates Foundation and endorsed by the G-8 countries also will provide a new and vital boost to help for
